Assignee
MEDA PHARMA GMBH & CO KG
DE·9 granted patents·2 pending applications·111 citations·filing 2000–2018
Top patents by PatentIndex Score
11 records- 0190US7985766B2Combination of anticholineric and β mimetics for the treatment of respiratory diseasesMEDA PHARMA GMBH & CO KG·Filed 2007·Granted Jul 26, 2011·16 cites·7 claims
- 0283US8048910B2Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseasesMEDA PHARMA GMBH & CO KG·Filed 2006·Granted Nov 1, 2011·16 cites·10 claims
- 0378US7234464B2Storage system for powdered pharmaceuticals, and inhaler equipped with this systemMEDA PHARMA GMBH & CO KG·Filed 2000·Granted Jun 26, 2007·63 cites·19 claims
- 0472US7569598B2Process for the preparation of the R,R (or S,S) configured glycopyrronium stereoisomerMEDA PHARMA GMBH & CO KG·Filed 2003·Granted Aug 4, 2009·7 cites·16 claims
- 0570US7521438B1Combination of loteprednol and β2-adrenoceptor agonistsMEDA PHARMA GMBH & CO KG·Filed 2000·Granted Apr 21, 2009·5 cites·6 claims
- 0665US8008319B2Treatment of colorectal polyps with imidazoquinoline derivativesMEDA PHARMA GMBH & CO KG·Filed 2009·Granted Aug 30, 2011·0 cites·15 claims
- 0760US7553858B2Combination of flupirtine and tramadolMEDA PHARMA GMBH & CO KG·Filed 2004·Granted Jun 30, 2009·2 cites·21 claims
- 0858US7208609B2Method for producing thioctic acidMEDA PHARMA GMBH & CO KG·Filed 2003·Granted Apr 24, 2007·2 cites·9 claims
- 0945US2008095741A1R-(+)-alpha-liponic acid for the prevention of diabetesMEDA PHARMA GMBH & CO KG·Filed 2007·Application pending·0 cites
- 1040US10975097B2Process to convert technical ascomycin into purified pimecrolimusMEDA PHARMA GMBH & CO KG·Filed 2018·Granted Apr 13, 2021·0 cites·27 claims
- 1135US2015072006A1Pharmaceutical FormulationsMEDA PHARMA GMBH & CO KG·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when MEDA PHARMA GMBH & CO KG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →